fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Permethrin

All products: general benefit

Kwellada-P Lotion · DIN 02231348 · 5% · Lot

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Kwellada-P Lotion · DIN 02231348 Manufacturer: MedTech Products Inc.; listing date 1998-12-31 Health Canada: Marketed since 2013-02-15 · brand KWELLADA-P LOTION · ATC P03AC04 PERMETHRIN · form Lotion · route Topical · ingredients PERMETHRIN 5 % · company Medtech products inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Kwellada-P Lotion: Formulary list price $0.51 per unit (the source does not state the unit; exact figure $0.5053). What the ministry pays, not the patient.

Ministry pays: $0.5053 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02231348)

Source record
DIN 02231348: Kwellada-P Lotion Raw flags: sec3=Y Item: 840412014; group id 828; item number 2017; lccId None; manufacturer id MEP Source form: Lot; strength: 5% Recorded listing: General benefit Source prices (unrounded): $0.5053; ministry $0.5053 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02231348 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50657
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02231348
Shortage record checked October 6, 2026

Other products in the same Health Canada class (P03A, P03AC): coverage varies; not interchangeable

  • Piperonyl butoxide + pyrethrins (R & C Shampoo with Conditioner): general benefit
  • Dimethicone (Nyda): general benefit
  • Isopropyl myristate (Resultz): general benefit
Other drugs in the same formulary class (84:04:12 Parasiticides) and how they are covered

Matched class: 84:04:12 Parasiticides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DIMETHICONE., ISOPROPYL MYRISTATE, PYRETHRINS & PIPERONYL BUTOXIDE 84:04:12 Parasiticides

PYRETHRINS & PIPERONYL BUTOXIDE

· 1 products · General benefit · strengths: 0.33% & 3% · Topical Shampoo

DIMETHICONE.

· 1 products · General benefit · strengths: 50% w/w · Top Sol-50mL Pk

ISOPROPYL MYRISTATE

· 2 products · General benefit · strengths: 50% · Top Sol-120mL Pk, Top Sol-240mL Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:12
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:08 Fungicides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS NIX® CRÈME RINSE (Permethrin 1% cream) is indicated for the treatment of infestation with head lice and their nits (eggs). 1.1 Pediatrics Pediatrics (two years and older): Health Canada has authorized an indication for pediatric use (two years and older). Safety and effectiveness in children less than two years of age have not been established. 1.2 Geriatrics Geriatrics (> 65 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use. https://pdf.hres.ca/dpd_pm/00069000.PDF PM date: Apr 29, 2003 Source product: NIX CREME RINSE; DIN 00771368; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.